Science FDA Approves Journavx Drug to Treat Pain Without Addiction Risk January 31, 2025 The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. About The Author See author's posts Continue Reading Previous: All 67 feared dead as airliner, army copter collide, crash into DC riverNext: Doug Burgum Is Confirmed by Senate as Interior Secretary Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related Stories Science Eeny Meeny Miny Mo, Catch a Pterosaur by Its Neck January 30, 2025 Science Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africa January 30, 2025 Science Asteroid 2024 YR4 Could Strike Earth, Researchers Say, But the Odds are Small January 30, 2025